These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7163815)

  • 21. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etoposide and ifosfamide in combination for inoperable carcinoma of the bronchus.
    Schilcher RB; Seeber S; Scheulen ME; Schmidt CG
    Cancer Treat Rev; 1982 Jun; 9 Suppl():107-10. PubMed ID: 7127333
    [No Abstract]   [Full Text] [Related]  

  • 23. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer.
    Buzdar AU; Legha SS; Tashima CK; Yap HY; Hortobagyi GN; Hersh EM; Blumenschein GR; Bodey GP
    Cancer Treat Rep; 1979 Jan; 63(1):115-20. PubMed ID: 369682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
    Prescrire Int; 1998 Apr; 7(34):45-7. PubMed ID: 10183382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of ifosfamide toxicity using dose fractionation.
    Rodriguez V; Bodey GP; Freireich EJ; McCredie KB; McKelvey EM; Tashima CK
    Cancer Res; 1976 Aug; 36(8):2945-8. PubMed ID: 1277203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ifosfamide treatment of advanced ovarian cancer.
    Yazigi R; Wild R; Madrid J; Arraztoa J
    Obstet Gynecol; 1984 Feb; 63(2):163-6. PubMed ID: 6694809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma.
    Vose JM
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):33-7. PubMed ID: 8677446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination chemotherapy of advanced non-Hodgkin's lymphoma with adriamycin, vincristine, ifosfamide and prednisolone (AVIP): a preliminary report.
    Ohnoshi T; Oka A; Hayashi K; Ueoka H; Sato M; Nishihara R; Yasuoka M; Sando Y; Tanaka T; Kimura I
    Acta Med Okayama; 1982 Feb; 36(1):67-72. PubMed ID: 7064735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modern chemotherapy of a malignant testicular tumors (author's transl)].
    Arnold H; Fiebig HH
    Radiologe; 1981 Sep; 21(9):421-30. PubMed ID: 6170087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone].
    Sezaki T; Ishii H; Osada T; Adachi T; Takahashi I; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1982 Jun; 23(6):847-53. PubMed ID: 7176091
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical studies of ifosfamide for gynecological malignancies].
    Kohno I; Kazuta M; Miyao J; Kunimi N; Kawamoto M; Tanimura T; Fujiwara K; Sekiba K
    Gan To Kagaku Ryoho; 1983 May; 10(5):1278-84. PubMed ID: 6870299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ifosfamide-induced renal tubular defects.
    Patterson WP; Khojasteh A
    Cancer; 1989 Feb; 63(4):649-51. PubMed ID: 2914270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical experience with the cytostatic drug ifosfamide].
    Ritter S; Schröder HJ
    Med Welt; 1977 Sep; 28(35):1395-1400. PubMed ID: 70737
    [No Abstract]   [Full Text] [Related]  

  • 34. High-dose ifosfamide with mesna uroprotection: a phase I study.
    Elias AD; Eder JP; Shea T; Begg CB; Frei E; Antman KH
    J Clin Oncol; 1990 Jan; 8(1):170-8. PubMed ID: 2104923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclophosphamide toxicity in Ugandan and American patients with malignant lymphoma.
    Brown CH; Ziegler JL; Templeton C; Carbone PP
    Cancer; 1970 Aug; 26(2):462-7. PubMed ID: 5451221
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of bone marrow toxic reaction in patients treated with allopurinol.
    Stolbach L; Begg C; Bennett JM; Silverstein M; Falkson G; Harris DT; Glick J
    JAMA; 1982 Jan; 247(3):334-6. PubMed ID: 7033573
    [No Abstract]   [Full Text] [Related]  

  • 38. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
    J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin and ifosfamide combination chemotherapy in previously treated acute leukemia in adults: a Southwest Oncology Group pilot study.
    Ryan DH; Bickers JN; Vial RH; Hussein K; Bottomley R; Hewlett JS; Wilson HE; Stuckey WJ
    Cancer Treat Rep; 1980; 64(8-9):869-72. PubMed ID: 7448824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.